Standout Papers

Biomarker Analyses and Fi... 2011 2026 2016 2021 2011 2012 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation benchmark for papers published in the same subfield and year, or reaches the top citation threshold in at least one of its specific research topics.

  1. Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients With Advanced Non–Small-Cell Lung Cancer in Asia (IPASS)
    2011 1.2k citations Masahiro Fukuoka, Yi‐Long Wu et al. Journal of Clinical Oncology profile →
  2. Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy (LUX-Lung 1): a phase 2b/3 randomised trial
    2012 775 citations Vincent A. Miller, Vera Hirsh et al. The Lancet Oncology profile →

Immediate Impact

3 by Nobel laureates 7 from Science/Nature 85 hit
Sub-graph 1 of 17

Citing Papers

AGA Clinical Practice Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation in At-Risk Individuals
2025 Hit
The benefits of GLP-1 drugs beyond obesity
2024 HitScience
23 intermediate papers

Works of Tsu-Yi Chao being referenced

Insulin Resistance Promotes Parkinson’s Disease through Aberrant Expression of α-Synuclein, Mitochondrial Dysfunction, and Deregulation of the Polo-Like Kinase 2 Signaling
2020
A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: A randomized trial
2008
and 2 more

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Tsu-Yi Chao 2.3k 2.0k 1.5k 826 493 102 4.4k
John Hamm 4.0k 1.7× 1.6k 0.8× 1.1k 0.7× 1.3k 1.6× 716 1.5× 74 5.2k
Y Ariyoshi 3.2k 1.4× 2.8k 1.4× 2.0k 1.3× 425 0.5× 695 1.4× 126 5.5k
Zhen Fan 3.0k 1.3× 1.4k 0.7× 2.5k 1.6× 1.0k 1.3× 484 1.0× 70 5.6k
Miguel A. Villalona‐Calero 3.1k 1.4× 2.1k 1.0× 2.7k 1.8× 1.1k 1.3× 398 0.8× 187 6.4k
Markus Borner 3.0k 1.3× 1.8k 0.9× 1.8k 1.2× 824 1.0× 240 0.5× 125 5.5k
Masashi Bando 2.5k 1.1× 4.7k 2.4× 2.0k 1.3× 1.2k 1.5× 544 1.1× 139 6.7k
Makoto Maemondo 4.3k 1.9× 4.5k 2.3× 1.8k 1.2× 884 1.1× 457 0.9× 181 6.3k
Kaoru Tanaka 2.2k 1.0× 1.3k 0.7× 1.1k 0.7× 451 0.5× 282 0.6× 112 3.7k
Hisanori Uehara 1.7k 0.7× 1.7k 0.9× 2.3k 1.5× 954 1.2× 233 0.5× 135 5.0k
Kyung-Hun Lee 4.1k 1.8× 1.9k 1.0× 1.6k 1.1× 1.5k 1.9× 448 0.9× 216 5.9k

All Works

Loading papers...

Rankless by CCL
2026